feed,title,long_url,short_url
SeekingAlpha,Apellis falls as EU experts decline to back eye disorder therapy,https://seekingalpha.com/news/4120593,
SeekingAlpha,Bristol-Myers Squibb: Time To Double Down,https://seekingalpha.com/article/4701500,
SeekingAlpha,CLO Closed-End Funds: Baby Bonds And Preferred Offering Steady Income,https://seekingalpha.com/article/4701499,
SeekingAlpha,Argenx: Strong Setup For Outperformance In 2025,https://seekingalpha.com/article/4701498,
SeekingAlpha,Zscaler Vs. Crowdstrike: Which Of These Two Great Companies To Buy Now,https://seekingalpha.com/article/4701497,
